Walleye Trading LLC Crinetics Pharmaceuticals, Inc. Transaction History

Walleye Trading LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$25.62 - $37.07 $1.09 Million - $1.58 Million	-42,706 Reduced 68.89%	19,290 $686,000
Q3 2023 Nov 14, 2023	BUY	$15.97 - $30.59 $669,174 - $1.28 Million	41,902 Added 208.53%	61,996 $1.84 Million
Q2 2023 Aug 14, 2023	SELL	$15.73 - $23.6 $79,593 - $119,416	-5,060 Reduced 20.12%	20,094 $362,000
Q1 2023 May 15, 2023	BUY	$15.31 - $21.1 $112,161 - $154,578	7,326 Added 41.09%	25,154 $403,000
Q4 2022 Feb 14, 2023	SELL	$15.49 - $19.05 $75,049 - $92,297	-4,845 Reduced 21.37%	17,828 $326,000
Q3 2022 Nov 14, 2022	BUY	$18.11 - $22.37 $410,608 - $507,195	22,673 New	22,673 $445,000

242

79.6M

23.3K

44.3K

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.98B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.